More From Nivedha Elango
Minnesota Cannabis Legalization: A Work in Progress
Marijuana legalization is a recurring subject of discussion in the US, and the debate about marijuana’s benefits is ongoing. What’s the latest in Minnesota?
FSD Pharma Reported Q3 Earnings after Losses
Cobourg-based cannabis operation FSD Pharma (HUGE.CN) (FSDDF) recently announced its third-quarter earnings fiscal 2019 results on November 29. The results are for the three month period ending on September 30, 2019. Since the time of the announcement, the stock has been trading in the same line. Currently, it’s trading at $4.89. FSD Pharma financial highlights […]
A CBD Comparison: Hemp versus Marijuana
As medical marijuana is legal in several countries, CBD has become a frequently used medicine. Two types of cannabis plants produce CBD: hemp and marijuana.
A Closer Look at Arizona’s Marijuana Laws
Arizona is one US state with strong opposition to marijuana legalization. It legalized the use of medical marijuana in 2010 after many failed initiatives.
Your Guide to Ohio Marijuana Law
Ohio legalized the medical use of marijuana in 2016, but it’s failed in its attempts to legalize the recreational use of cannabis.
Why Alberta Is Holding Off on Vaping Products
It looks like vaping products won’t be available in the Alberta cannabis market anytime soon. Though Canada permits their sale, the province is skeptical.
Analyst Believes Curaleaf Still Has Room to Grow
Beacon Securities analyst Russell Stanley expects Curaleaf stock to grow 255% in the next 12 months. Stanley gave a target price of 25 Canadian dollars.
Tilray’s Latest Ratings: Analysts Are Undecided
Tilray has frequently been in the news lately. Despite its efforts, its stock has continued to fall for the last month. It’s currently trading at $17.31.
Tilray Exports to Switzerland and 13 Other Countries
In recent news, Tilray Inc. (TLRY) exported medical marijuana to Switzerland. The company exported medical marijuana extracts to cater to the needs of patients in Switzerland. Apart from Switzerland, TLRY exports to medical cannabis markets in 13 other countries. Tilray’s exports Tilray exported medical marijuana extracts from its GMP-certified facility to Switzerland. The company got […]
A Curaleaf Overview: Origins, Products, and More
Curaleaf Holdings (CURLF) (CURA) is one of the leading vertically integrated cannabis players in the US. The company has operations in 12 states.
Trulieve Is Under Attack from Short Sellers
In recent news, short seller Grizzly Research released a report attacking leading cannabis company Trulieve Cannabis (TRUL) (TCNNF)..
A Guide to Marijuana Laws in Michigan
The launch of recreational cannabis products in Michigan was scheduled for spring 2020. The Marijuana Regulatory Agency moved the launch to December 1.
Green Thumb, Liberty Health Open New Locations
Recently, leading cannabis companies Green Thumb Industries (GTBIF) and Liberty Health Sciences (LHSIF) launched retail stores in new locations.
Understanding MedMen’s Cannabis Logistics Software
Cannabis retailer MedMen Enterprises (MMNFF) has partnered with Onfleet software to handle its multistate logistics.
How Texas Marijuana Law Has Evolved Over the Years
Texas marijuana laws have been some of the most conservative in the US, but that’s slowly changing. Let’s take a closer look.
What the MORE Act Would Mean for the US
Cannabis is still listed as a Schedule I drug under US federal law. The most recent bill introduced to change this situation is the MORE Act.
What Tilray’s New License Means for It
On December 11, Tilray’s (TLRY) wholly-owned subsidiary, Tilray Portugal, received an additional Good Manufacturing Practice certification.
The SQDC Is Cashing In on Cannabis in Québec
The SQDC (Société Québécoise du Cannabis), which got its start more than a year ago, recorded huge profits in the second quarter of fiscal 2020.
US Cannabis Legalization: The Latest Updates
Medical cannabis is legal in 33 US states, recreational cannabis is legal in 11, and 15 states have decriminalized it. These numbers might soon increase.
Does Texas Want Marijuana Legalized?
Texas has some of the most restrictive marijuana laws in the US. Medical marijuana is permitted in some cases, and recreational marijuana is illegal.
Aurora Eyes the US Cannabis Market
Aurora Cannabis (ACB) (ACB.TO) is a Canadian cannabis giant, but the company’s plans to enter the US market keep getting delayed.
Cannabis: Legal Market versus Black Market
The cannabis industry has been growing exponentially for the past few years. As the cannabis market keeps growing, the black market is growing too.
Aurora Cannabis Gets Product Approval in Ireland
Aurora Cannabis recently received approval to use one of its oil products under Ireland’s Medical Cannabis Access Programme.
Edibles and You: The Effects of Ingesting Cannabis
With Cannabis 2.0 rolling out, cannabis companies are working on innovative product lines to secure their shares of the new edibles market.
Aphria: A Company Overview and a Look at 2020
Aphria produces and sells medical and recreational cannabis in Canada via award-winning brands. It aims to be the world’s best-performing cannabis company.
Khiron Life Science Q3 Earnings Update
Toronto-based cannabis player Khiron Life Science (KHRN) announced its third-quarter fiscal 2019 earnings results on November 26. Since the time of the announcement, the stock fell by more than 7%. Currently, it’s trading at $0.90. Khiron Life Science financial highlights Khiron Life Science reported revenue of $2.8 million in the third quarter. The revenue consists of […]
Trump Administration Sets Minimum Age for Vaping
In recent news, President Donald Trump proposed a minimum age of 21 for using e-cigarette products. Trump previously expressed his support to ban vaping. However, he changed his mind as he believes the ban will lead to a rise in the black market. As the country took a big hit due to vaping illness, this action […]
US Government Prohibits Funding for Marijuana
In a recent update on the standoff between state and federal government, the US government cut federal grants for treatments using medical marijuana. This move by the federal government goes against the states that legalized marijuana for medical conditions without significant scientific evidence. This is especially true for the states that allow marijuana treatment for […]
Raymond James on Cannabis Sector Outlook
After a long stretch of time, the cannabis sector had a good week as some of the companies reported profits. Many analysts see this as a positive sign for investors in the industry. Rahul Sarugaser, an analyst for Raymond James, recently pointed to the improvements in the US legal framework as well as the Ontario […]
How MedMen Is Staking Its Claim in Cannabis Retail
Major US cannabis retailer MedMen aims to expand its brand by increasing its number of flagship retail stores and offering high-quality cannabis products.
Aurora Cannabis Opens Flagship Store in Edmonton
Aurora Cannabis has announced the opening of its new flagship retail store. This new operation is located in the West Edmonton Mall in Edmonton, Alberta.
Planet 13 Stock Is Down 15% Since Its Q3 Earnings
Planet 13 Holdings announced its third-quarter earnings results on November 25. Since the time of the announcement, the stock has fallen 15%.
Canopy Growth Gets Beverage Facility License
On November 22, Canopy Growth received a license from Health Canada for a 150,000-square-foot beverage-production facility in Smiths Falls, Ontario.
Is the Cannabis Industry Dead or Alive?
The cannabis industry has seen massive growth in recent years, but marijuana stocks have been plummeting lately. Are these indications of a dying industry?
Does Canopy Growth Have Leadership Issues?
Canopy Growth recently reported pretty dismal quarterly results. Some suggest that the company’s headwinds are the result of terrible governance.
Aurora Cannabis Hit with Securities Lawsuits
Recently, three law firms filed lawsuits against Aurora Cannabis to investigate claims representing the buyers of Aurora Cannabis securities.
Illegal Cannabis Market Overshadows Legal One
Cannabis companies expect Cannabis 2.0 to improve their top lines and profitabilities. However, illegal cannabis already has a considerable market share.
Scotts Miracle-Gro: Analysts’ Ratings after Q4
Scotts Miracle-Gro released its fiscal 2019 fourth-quarter and full-year results on November 6. Its stock has fallen 3.55% since its earnings release.
KushCo: 6 Analysts Say “Buy,” Price Target Shrinks
KushCo Holdings (KSHB) recently announced its fourth-quarter and full-year financial results. The company reported impressive results, beating analyst estimates. The company’s stock is trading in the same line since the day of the earnings release. Currently, the stock is trading at $1.83 as of November 21. KushCo financial highlights KushCo analysts reported $47 million in […]
Arizona Marijuana: Five Key Takeaways
Arizona is a conservative state when it comes to marijuana laws. The state allowed the use of medical marijuana in 2010. The proposal for allowing medical marijuana passed after years of failed propositions. Currently, recreational marijuana is illegal in the state. However, the state is preparing for a proposition to allow recreational marijuana in 2020. […]
Charlotte’s Web: An Overview of a Cannabis Giant
Charlotte’s Web Holdings, Inc. (CWEB) is a US-based vertically integrated CBD producer. The company focuses on making and distributing hemp-derived CBD products. Charlotte’s Web’s mission is to help people find peace in mind, body, and soul. Further, the company aims to meet the consumer’s demands for quality products, efficiency, and consistency. Initial development Charlotte’s Web […]
HEXO Corp: Analysts’ Ratings and Price Target
HEXO Corp (HEXO) is a Canada-based cannabis company. Recently, the company announced its fourth-quarter results for the period ending on July 31, 2019. The company’s revenue missed the estimates of the analysts. HEXO’s stock value fell by 20% from the time of the earnings release. Also, the company’s stock is currently traded at $1.79. HEXO’s […]
Candidates Condemn Biden’s Gateway Drug Views
Joe Biden said that using recreational marijuana might be considered a gateway drug. He received criticism from many of his fellow candidates.
Canopy Growth’s Q2 Earnings: Top Five Takeaways
Leading cannabis producer Canopy Growth reported disappointing fiscal 2020 second-quarter earnings results on November 14.
Canopy Growth: An Overview of the Cannabis Giant
Canopy Growth operates in 14 countries on five continents. The company has expanded through strategic partnerships, acquisitions, and supply agreements.
Acreage’s Q3 Missed Expectations, but It’s Optimistic
Acreage Holdings reported its third-quarter earnings results on November 12. The company’s earnings were lower than analysts’ expectations.
Tilray Tumbles following Its Q3 Earnings Report
Tilray reported its third-quarter earnings results on November 12. It reported five times its revenue from last year’s third quarter.
Aleafia Health Hits a Profit Milestone in Q3
Aleafia Health reported its third-quarter earnings results on November 12. The cannabis producer reported a positive net profit for the first time.
GW Pharmaceuticals: Analysts’ Ratings, Price Target
GW Pharmaceuticals (GWPH) recently reported its QA3 results. Although its financials beat estimates, the company’s stock has fallen 18% since then.
Canopy Growth Sponsors Clinical Trial of CBD
According to recent news, Canopy Growth is sponsoring a clinical trial exploring CBD’s effects on social anxiety disorder.
OrganiGram’s Q4: Big 2019 Growth, Big 2020 Plans?
OrganiGram is set to report its fiscal 2019 fourth-quarter earnings results on November 25. It will report its numbers for the quarter and the full year.
Why Cronos’s Listing in Australia Is Important
Cronos Australia (CAU.AX) was recently listed on the Australian Stock Exchange. Its IPO recently raised 20 million Australian dollars.
Canopy Rivers Gears Up for Cannabis 2.0
Canopy Rivers is gearing up to take advantage of the Cannabis 2.0 market, and it has a laundry list of subsidiary companies to help it do so.
Tilray: What to Expect from Its Q3 Earnings
Global cannabis producer Tilray (TLRY) plans to announce its Q3 results on November 12. So far this month, Tilray’s stock price has risen by 2.6%.
Cresco Labs Kicks Off Its Incubator Program in Illinois
Cresco Labs launched its incubator program in Illinois on November 6. This program is part of Cresco’s Social Equity and Educational Development initiative.
KushCo Launches New Hemp Trading Business
KushCo is expanding its CBD footprint by launching a hemp trading business. KushCo is promoting hemp trading with farmers and a verified buyer network.
Is Michigan Rolling Out Recreational Licenses?
Michigan is rolling out licenses for recreational cannabis businesses. The state’s Marijuana Regulatory Agency has been accepting applications since November 1, 2019.
Cannabis: Why Quebec Raised the Legal Age to 21
Quebec recently passed a bill to raise the legal age for cannabis consumption from 18 to 21. This law will become effective on January 1, 2020.
Curaleaf Buys Acres Cannabis and MACHNV LLC
Curaleaf Holdings, Inc. (CURLF) (CURA) recently closed a deal with Acres Cannabis. Curaleaf bought Acres’ cultivation and production facilities in Amargosa Valley, Nevada. This 269,000-square-foot facility is for processing. With this deal, the company can expand its cultivation and processing operations in Nevada. Details of the deal On March 18, 2019, Curaleaf signed a deal […]
MedMen Buds: Loyalty Program Information
MedMen (MMNFF) is a vertically integrated cannabis retailer with its footprint across the US. The company is in nine states and has 32 stores and 70 retail licenses. Recently, the company launched a loyalty program called MedMen buds. Also, the company launched its omnichannel delivery services in August. What is MedMen Buds? MedMen Buds is […]